Doctor profile · Federal record
Dr. John Piede, MD
Hematology & Oncology Physician (CMS: Medical Oncology) · Birmingham, AL
- NPI 1972782548
- Accepts Medicare
- MIPS 78.7 / 100 · 2023
- 20 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2728 10Th Ave S Ste 200
Birmingham, AL 352051202
(205) 930-7880
fax (205) 930-2509
Credentials & registration
- NPI registered
- October 2007 — 19 yrs on file
- Profile last updated
- December 18, 2018
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Alabama #32392
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972782548. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
73,907
Distinct HCPCS
10
Medicare allowed
$979,779
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 36,210 | 31 | $1 | |
J0897 |
Injection, denosumab, 1 mg | 12,120 | 51 | $23 | |
J1453 |
Injection, fosaprepitant, 1 mg | 6,900 | 11 | $0 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 5,960 | 14 | $42 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 5,670 | 11 | $45 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,587 | 37 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,320 | 31 | $1 | |
36415 |
Insertion of needle into vein for collection of blood sample | 828 | 341 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 491 | 275 | $83 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 390 | 12 | $0 |
In context: peer comparison
Among 34 peers in this city , average services per provider: 1,964. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$887
Transactions
46
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $335.17 | |
| ABBVIE INC. | 7 | $134.06 | |
| Merck Sharp & Dohme LLC | 4 | $112.80 | |
| PFIZER INC. | 5 | $82.58 | |
| Deciphera Pharmaceuticals Inc. | 2 | $50.66 | |
| Daiichi Sankyo Inc. | 2 | $42.56 | |
| Astellas Pharma US Inc | 2 | $33.03 | |
| GlaxoSmithKline, LLC. | 1 | $21.73 | |
| Iovance Biotherapeutics, Inc. | 1 | $21.31 | |
| Gilead Sciences, Inc. | 1 | $18.48 | |
| AstraZeneca Pharmaceuticals LP | 1 | $18.39 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $16.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,147
Patients
276
Total drug cost
$2,901,236
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 228 | 65 | $13,535 |
| Hydroxyurea | Generic | 154 | 26 | $3,783 |
| Eliquis (Apixaban) | Brand | 113 | 23 | $76,567 |
| Ondansetron Odt (Ondansetron) | Brand | 97 | 60 | $6,647 |
| Imbruvica (Ibrutinib) | Brand | 80 | 0 | $1,276,518 |
| Gabapentin | Generic | 72 | 17 | $822 |
| Promethazine Hcl | Generic | 65 | 24 | $1,217 |
| Dexamethasone | Generic | 54 | 32 | $1,139 |
| Acyclovir | Generic | 47 | 0 | $1,003 |
| Pomalyst (Pomalidomide) | Brand | 43 | 0 | $735,055 |
Hospital affiliations
Frequently asked questions
What is Dr. John Piede's medical specialty?
Dr. John Piede practices Hematology & Oncology Physician in Birmingham, AL.
Where does Dr. John Piede practice?
Dr. John Piede practices at 2728 10Th Ave S Ste 200, Birmingham, AL 352051202. Office phone: 2059307880.
What is Dr. John Piede's NPI?
Dr. John Piede's National Provider Identifier (NPI) is 1972782548, issued by NPPES.
Does Dr. John Piede accept Medicare assignment?
Yes. Dr. John Piede accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. John Piede commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, denosumab, 1 mg (HCPCS J0897); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.